Nebius Group (NBIS)

Investment Review After Q1 FY2026 Earnings (2026.05.13)
TL;DR
Nebius is an AI-native hyperscaler — full-stack GPU cloud (compute / storage / Token Factory / agentic) competing alongside CoreWeave and the big-3 hyperscalers. Just reported: Q1 FY2026 revenue $399M (+684% YoY, +75% QoQ), ARR $1.9B (+50% QoQ), Group adj EBITDA margin 13% (Nebius AI biz 45%) — strong inflection. Q2 guide implies margin step-down then Q3 recovery; FY26 reiterated at $7-9B ARR exit, $3-3.4B Group revenue, ~40% adj EBITDA. Stock at $209 (NM P/E(ttm), TTM OP still negative) — premium prices a $27B Meta contract, $20-25B CapEx ramp, and 4GW+ contracted power.

Summary

FindingAssessment
Post-Spin Stock Return$25 (Aug 2024) → $209 (current). Up ~735% in 21 months. Q1 print added +17%. Stock now trades on ARR multiple, not P/E.
Business ModelAI-native hyperscaler — full-stack cloud (compute + storage + Token Factory + agentic). 98% of revenue from Nebius AI biz. Adj EBITDA 45% margin on AI biz.
Competitive MoatNARROW Owns 75% of contracted power, NVIDIA Exemplar Cloud, Token Factory + acquisitions. Single GPU supplier risk; hyperscaler concentration.
Past DriversYandex spin-out (Aug 2024), Microsoft + first Meta contracts (anchor demand), NVIDIA $2B equity (2026), 3 acquisitions (Tavily, Eigen AI, Clarifai).
Recent Stock Move$85 (Q4 2025) → $209 (current). Driven by Meta $27B contract + raised CapEx guide + 45% AI biz adj EBITDA margin.
Revenue TrendACCELERATING Rev YoY: 684% (Q1 2026) → 784% (Q2 2026E).
Margin TrendCOMPRESSING OM%: -32% (Q1 2026) → -37% (Q2 2026E).
TTM OP TrajectoryDECLINING TTM OP QoQ: +1% (Q1 2026) → +39% (Q2 2026E). TTM OP -$604M (loss widening to -$837M Q2E).
Key OpportunitiesMeta $27B contract ($12B fixed + $15B optional); 4GW+ contracted power; FY26 ARR exit $7-9B; software stack deepening.
Key Risks$20-25B CapEx vs $3-3.4B Rev = 6-8x ratio; single GPU supplier; hyperscaler concentration; valuation rests on ARR not earnings.
CatalystsQ2 print, Q3 capacity inflection, FY26 ARR exit $7-9B, Meta first delivery early 2027, Vera Rubin H2 2026.
P/E(ttm) ValuationNM TTM OP negative. Valuation drives off ARR multiple: $209 stock × 254M shares = $53B market cap on $1.9B ARR = ~28x ARR; ~7x exit FY26 ARR midpoint.

Q1 FY2026 Key Data

Key Takeaways from Earnings Call

Key Segments and Revenue Mix (Q1 FY2026)

SegmentQ1 2026 Revenue% of GroupKey Details
Nebius AI (core cloud)$390M98%+841% YoY, +82% QoQ. ARR $1.9B end-Q1. Adj EBITDA margin 45%. Full-stack: bare metal + multi-tenant + Token Factory + Aster 3.5 + agentic. Customers: AI natives, Revolut, Sword Health, 1X Tech, monday.com, etc.
Avride + TripleTen + equity stakes$9M2%Avride (AV / delivery robots), TripleTen (edtech reskill). Equity stakes in ClickHouse + Toloka (Q1 ClickHouse mark-up drove $621M GAAP NI). Both still early-stage and EBITDA-negative.

Group structure: Nebius AI is the cash-generating cloud business (98% of revenue and the entirety of EBITDA growth). Strategic intent: find partners for Avride / TripleTen so they can scale outside the consolidation perimeter. Equity stake mark-to-market gains (ClickHouse Q1) inflate GAAP NI vs underlying operations. Headquarters Amsterdam; listed NASDAQ. Reporting currency USD.

Business Model

SUPPLIERS

NVIDIA (GPU monopoly — $2B equity tie + Exemplar Cloud status on GB300)
Power suppliers (PA, NJ, MO, AL)
Data center sites (4GW+ contracted)
Convert debt + ABS funders

GPUs / Power / $
NEBIUS

Full-stack AI cloud: compute + storage + network
Token Factory (inference) + agentic (Tavily)
Aster 3.5 platform; in-house chip ops
Owned 75%+ of contracted power
Q1 Rev $399M; ARR $1.9B; FY26 guide $3-3.4B

GPU-hours / tokens / API $ Revenue
CUSTOMERS

Hyperscalers (Meta $27B; Microsoft)
AI-natives (model builders, foundation labs)
Enterprises (Revolut, Sword Health, 1X)
Physical AI / pharma / FS / mfg / energy

Moat Assessment: NARROW

Stock vs. Earnings — Performance

Chart 1: Stock vs TTM OP & FCF

Past Key Drivers

Quarterly Key Metrics

USDQ1'24Q2'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26E
Quarter EndMar24Jun24Sep24Dec24Mar25Jun25Sep25Dec25Mar26Jun26
Stock---$27$22$52$110$85$104$209
Stock QoQ-----17%+132%+113%-23%+22%+101%
Rev YoY-----625%355%272%684%784%
OM%--774%-251%-290%-236%-106%-89%-103%-32%-37%
R40 (RevYoY+OM%)-----519%266%169%652%747%
TTM OP ($M)-$92-$204-$285-$462-$491-$490-$539-$596-$604-$837
TTM OP QoQ-+122%+39%+62%+6%+0%+10%+11%+1%+39%
FCF/OP-86%-77%25%122%276%438%547%617%527%711%
Debt/EBITDA-0.2x-0.1x-0.1x-0.1x-0.7x-5.8x-30.4x-83.8x76.2x69.0x
P/E(ttm)NMNMNMNMNMNMNMNMNMNM

Recent Stock Performance & Drivers

Opportunities

Challenges

Next 12 Months

Next 12-24 Months

Core Metrics Scorecard

Q3'21Q4'21Q1'22Q2'22Q3'22Q4'22Q1'23Q2'23Q3'23Q4'23Q1'24Q2'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26E
Quarter EndSep21Dec21Mar22Jun22Sep22Dec22Mar23Jun23Sep23Dec23Mar24Jun24Sep24Dec24Mar25Jun25Sep25Dec25Mar26Jun26
R40 > 40%
R40 accelerate
TTM OP QoQ > 10%
TTM OP QoQ accelerate
TTM FCF/OP > 60%
Debt/EBITDA < 3.5
Total passes----------------4435
Stock QoQ---------------17%+132%+113%-23%+22%+101%
P/E(ttm)-------------NMNMNMNMNMNMNM

Chart: R40 vs Stock Price (Since 2020)

Chart 2: R40 vs Stock Price

Chart: Scorecard Total Passes vs Stock Price (Since 2020)

Chart 3: Total Passes vs Stock Price
Source: SEC EDGAR 20-F filings, company earnings conference calls, shareholder letter, financial results press release.
Disclaimer: This report is for educational purposes only. NO investment advice.